Stocks Build on Early Morning Gains, Tech Marches Higher

The Nasdaq hit another intraday high as Big Tech continues to advance

Deputy Editor
Jul 13, 2020 at 12:20 PM
facebook X logo linkedin

Another round of positive vaccine updates and strong a 55% annual jump in new home sales for June -- the biggest annual jump since the housing crash -- is pushing stocks even higher by the midway mark. Dow Jones Industrial Average (DJI) is up over 400 points, while the S&P 500 (SPX) and Nasdaq Composite (NDX) are also building off this morning's momentum. Big Tech has once more helped the latter hit a new intraday record high. Notably, Apple (AAPL) is seeing some sizable gains after several analysts hiked their price targets.

All of these updates are drawing attention from another alarming spike in COVID-19 cases throughout the U.S. Specifically in Florida, where 15,299 new cases were reported on Sunday -- marking the highest number of single-day cases reported for one U.S. state since the beginning of the pandemic. 

Continue reading for more on today's market, including:

  • Earnings beat puts pep in soda stock's step. 
  • Pot stock topples key trendline after analyst adjustment. 
  • Plus, PFE's options pits are on fire; ECOR bounds higher on FDA update; and one bombing biopharma to avoid.

Midday Market Stats July 13

Pfizer Inc. (NYSE:PFE) is leading the Dow components and seeing a lot of activity in its options pits today, with 120,000 calls crossing the tape so far -- five times intraday average -- compared to 11,000 puts. Most popular at the July 36 and 35 calls, which expire this Friday, July 17. At last check, the stock is up 4.9% at $35.48.

Bioelectronic name ElectroCore, Inc. (NASDAQ:ECOR) is the Nasdaq's best performer so far, after the Food and Drug Administration (FDA) signed off on emergency use of its nerve simulator in adults with COVID-19 symptoms. ECOR is up 158.8% at $2.20 at last check,and is set to close atop the formerly resistant 200-day moving average for the first time since September 2019. 

One of the worst performers on the Nasdaq is NextCure Inc (NASDAQ:NXTC), following the biopharmaceutical company's decision to discontinue trial testing on its lung cancer and ovarian cancer patient groups into the second phase of its 2-stage trial of its experimental immunotherapy drug. Additionally, NextCure's Chief Medical Officer announced his resignation from the company, bringing the shares of NXTC down 43.4% to $10.12, and drawing out bear notes from Piper Sandler and SunTrust Robinson. The equity is trading at an all-time low today after languishing just below the 20-day moving average for the past couple of months. 

NXTC Chart July 13


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI